Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @columbiacancer
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @columbiacancer
-
We are proud to partner with
@nyphospital to provide expert cancer care.#WorldCancerDay
#IAmAndIWill
https://twitter.com/nyphospital/status/1224694169458872320 …
0:10Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This
#WorldCancerDay
, join us as we work to reduce the burden of cancer on our patients, their families, our community, and the world. #IAmAndIWill
CC: @nyphospital /@ColumbiaMedpic.twitter.com/2HADDBTVbVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
.
@KalinskyKevin of@nyphospital and@columbiacancer highlights recent developments in triple-negative#breastcancer, including the potential role of#immunotherapy in the neoadjuvant setting#bcsmhttp://ow.ly/JnYg50ycyNUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Luspatercept reduced the severity of anemia in patients with lower-risk myelodysplastic syndromes. Dr. Joseph Jurcic of
@nyphospital@ColumbiaMed and colleagues share results from a phase 3 trial in@NEJM.http://ow.ly/wCxU50ybOwUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI: The first article in the new@AACR journal "Blood Cancer Discovery" has been published, and our own Riccardo Dalla-Favera is Editor-In-Chief! "Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia" http://ow.ly/1rcs50yag4m pic.twitter.com/h0ZsdFJXN0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our more than 180 members at the
#HICCC span six schools and 35 departments across@Columbia and@ColumbiaMed. Read more about how our researchers and physicians are translating discovery science into cutting-edge cancer care. http://ow.ly/Riye50yaeme pic.twitter.com/AVzzxOUvF4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At the
#HICCC, our discoveries change lives. Read our 2019 annual report, "Accelerating Towards A Cure." https://cancer.columbia.edu/accelerating-towards-cure …pic.twitter.com/pccBmlJiQhHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
We are proud that we finished GeriTalk (1-day communication skills training from
@vitaltalk) today. This is our 3rd year. Trained 8 fellows and 1 surgeon. Very fulfilling experience!@mehtaso99@MSHSGeriPalCare@columbiacancer@ColumbiaDoctors@ColumbiaMedHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to our own Dr. Arnold Han, who has been awarded the Rachleff Innovation Award from the
@DamonRunyon Foundation for research with the potential to significantly impact the prevention, diagnosis, and treatment of#cancer.https://cancer.columbia.edu/dr-arnold-han-wins-innovation-award-cancer-immunotherapy-research …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How have
@ColumbiaMed and@Columbia researchers advanced our understanding of the#abscopal effect? Sreyan Chowdhury (@sreyandipity) shares with@theNCI.https://twitter.com/theNCI/status/1222201289033076737 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
Trained 8 critical care fellows for communication (CriticalTalk, derived from
@vitaltalk). It was just a short 2h session, but still there were lots of learning. Only practice makes perfect! Appreciate the support by@vmoitra@hastie_md@ColumbiaCCM@CTICU_NYP@theSICUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At the 2020 Pancreas Symposium, hosted by the Pancreas Center at
@ColumbiaSurgery, experts from@nyphospital/@ColumbiaMed will review cutting-edge diagnostics and treatments and what's on the horizon for pancreas diseases.#PancSM Register below: http://ow.ly/39Qv50y6Lot pic.twitter.com/u8jPYSZmcb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
Today I participated in a symposium organized by
@columbiacancer and@CUSEAS as a new initiative to promote new collaborations between cancer and engineering research at@Columbia. Shout-out to@ARustgi and Mary Boyce for organizing and@GVNlab@Kam_S_Leong for great talks!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"This approval of Tazverik (tazemetostat) represents an important advancement in the treatment of patients with epitheliod sarcoma," says
@nyphospital/@ColumbiaMed oncologist Gary Schwartz. Read more via@CancerNetwrk: http://ow.ly/WeXY50y5NRX pic.twitter.com/8a0RFniCPf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to Steve Sastra - very well-deserved recognition for his leadership of the Mouse Hospital, an innovative facility within the
@KenOliveLab designed to recreate all aspects of a clinical trial while using mouse models.https://twitter.com/KenOliveLab/status/1220846280080887811 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
Thank you
@CR_AACR!@columbiacancer@nyphospital immunotherapy is a growing field and understanding biomarkers to improve treatment response is key. We started our first steps in melanoma now we battle children’s cancer.#Pediatrics#curehttps://twitter.com/CR_AACR/status/1220405896028852225 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What are the warning signs of
#CervicalCancer? Learn more from@nyphospital /@ColumbiaMed gynecologic oncologist Dr. Caryn St. Clair.https://www.shape.com/lifestyle/mind-and-body/signs-of-cervical-cancer …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
Mutant p53 on the Path to Metastasis from Rustgi and co
@columbiacancer@ColumbiaMed https://www.sciencedirect.com/science/article/pii/S2405803319302389?via%3Dihub …pic.twitter.com/2RXbnlfFJw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What has
@theNCI-MATCH trial taught us about#PrecisionMedicine? Read more about how the NCI-MATCH trial is helping researchers and physicians navigate the complexities of molecular profiling for targeted therapies. https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djz245/5699915 …pic.twitter.com/pOkVzJbUg3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Columbia Cancer proslijedio/la je Tweet
Damon Runyon Awards $3.8M to Innovative Early Career Scientists http://bit.ly/Innovators2020
@LironBarPeled@MGHCancerCenter@gsducker@HarvardGSAS@chemical_phd@MichaelPacold@PapaemmanuilLab@sloan_kettering@DanaFarberNews@columbiacancer@AmaiaLujambio@IcahnMountSinai@DukeHMCTpic.twitter.com/rHvaRi3IA7Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.